Study of Alzheimer’s Disease in Down Syndrome (LIFE-DSR)
This is an observational, multicenter, longitudinal cohort study to characterize adults with Down syndrome ages 25 years and above enrolled at specialized care centers. The aim is to assess changes in cognition, behavior, function, and health over approximately 24 months.
Blood will be collected for the development of plasma Alzheimer’s disease biomarkers useful in the Down syndrome population.